Palle Christophersen
Founder en SANA AB .
Fortuna: 157 694 $ al 31/03/2024
Perfil
Palle Christophersen is the founder of Saniona AB, which was founded in 2011.
He holds the title of Executive Vice President-Research at Saniona AB.
Dr. Christophersen is currently the Chief Scientific Officer at Saniona A.
Dr. Christophersen previously worked at NTG Nordic Transport Group A from 1991 to 2012, where he held the title of Vice President & Director-Vitro Pharmacology.
Dr. Christophersen obtained a doctorate degree from the University of Copenhagen.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
SANIONA AB
0.79% | 31/12/2022 | 874 571 ( 0.79% ) | 157 694 $ | 31/03/2024 |
Cargos activos de Palle Christophersen
Empresas | Cargo | Inicio |
---|---|---|
SANA AB | Founder | 01/01/2011 |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The private company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Chief Tech/Sci/R&D Officer | - |
Antiguos cargos conocidos de Palle Christophersen.
Empresas | Cargo | Fin |
---|---|---|
NTG NORDIC TRANSPORT GROUP A/S | Corporate Officer/Principal | 01/01/2012 |
Formación de Palle Christophersen.
University of Copenhagen | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
NTG NORDIC TRANSPORT GROUP A/S | Transportation |
SANA AB | Health Technology |
Empresas privadas | 1 |
---|---|
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The private company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Commercial Services |
- Bolsa de valores
- Insiders
- Palle Christophersen